Clin2
NCT07407400Worth exploringNot yet recruiting

Lemborexant for sleep and delirium prevention in elderly ICU patients

Sleep DisturbanceDeliriumCritical Illness

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests whether the sleep medication lemborexant can help prevent delirium and improve sleep in elderly patients staying in the surgical ICU. If you qualify, you would receive the study drug or a placebo to see if it helps you stay more alert and avoid confusion during your ICU stay.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • You are 65 years or older.
  • You are a patient in the surgical intensive care unit (SICU) and expected to stay for at least 48 hours.
  • You can take medications by mouth or through a feeding tube.
  • You are not currently taking strong sleep medications or sedatives.
  • You do not have severe liver or kidney disease, deep sedation, or certain unstable heart/lung conditions.
  • You have not been diagnosed with delirium in the past 12 hours.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06473415Recruiting
Lormetazepam for sleep in the ICU

This trial tests whether a sleep medication called lormetazepam can improve sleep quality and brain activity in ICU patients who are on a breathing machine. It may help if you need sedation and are expected to stay in the ICU for at least two days.

Mitte, State of Berlin
NCT06824077Not yet recruiting· Early Phase 1
Sleep study to reduce delirium in the ICU

This study tests if adding a calming medicine called dexmedetomidine to a sleep-promoting routine can help reduce delirium in ICU patients who are awake and on a breathing machine or high-flow oxygen.

NCT05713877Recruiting· Phase 2
Melatonin to treat confusion in ICU patients

This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.

Montreal, Quebec
NCT05069428Recruiting· Phase 4
Ramelteon to reduce confusion in ICU patients

This trial tests whether ramelteon, a sleep medicine, can reduce delirium—a sudden confusion problem—in people in the intensive care unit (ICU). If you qualify, it may help you (or your loved one) stay clearer and more comfortable during ICU treatment.

Nashville, Tennessee
NCT06648681Not yet recruiting· Phase 2
Lemborexant to prevent confusion after heart surgery

This trial tests if lemborexant, a sleep medication, can help prevent confusion (delirium) after open-heart surgery. If you are having heart surgery through a chest incision, you may be able to join.

Vancouver, British Columbia
NCT07695285Not yet recruiting· Phase 2
Lemborexant for improving thinking after confusion in older surgery patients

This trial tests if lemborexant can help older adults recover their thinking abilities after experiencing confusion following surgery. It compares lemborexant to a placebo to see if it improves cognitive function.

Hear when a new Sleep Disturbance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.